Literature DB >> 19336575

Genetic analysis of coronary artery disease single-nucleotide polymorphisms in diabetic nephropathy.

Amy Jayne McKnight1, Alexander P Maxwell, Damian G Fogarty, Denise Sadlier, David A Savage.   

Abstract

BACKGROUND: Diabetic nephropathy is a leading cause of end-stage renal disease. Premature mortality is common in patients with nephropathy, largely due to cardiovascular disease. Genetic variants implicated in macrovascular disease are therefore excellent candidates to assess for association with diabetic nephropathy. Recent genome-wide association studies have identified a total of 15 single-nucleotide polymorphisms (SNPs) that are reproducibly associated with cardiovascular disease.
METHODS: We initially assessed these SNPs for association in UK type 1 diabetic patients with (cases; n = 597) and without (controls; n = 502) nephropathy using iPLEX(TM) and TaqMan(R) assays. Replication studies were performed with DNA genotyped in a total of 2668 individuals from the British Isles.
RESULTS: One SNP (rs4420638) on chromosome 19q13 was found to be significantly associated with diabetic nephropathy before (P = 0.0002) and after correction for multiple testing (P(corrected) = 0.002). We replicated this finding in a phenotypically similar case-control collection comprising 709 individuals with type 1 diabetes (P = 0.002; combined P < 0.00001; OR = 1.54, 95% CI: 1.29-1.84).
CONCLUSIONS: Our case-control data suggest that rs4420638, or a functional SNP in linkage disequilibrium with this SNP, may be associated with diabetic nephropathy.

Entities:  

Mesh:

Year:  2009        PMID: 19336575     DOI: 10.1093/ndt/gfp015

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  4 in total

1.  SNP in the genome-wide association study hotspot on chromosome 9p21 confers susceptibility to diabetic nephropathy in type 1 diabetes.

Authors:  E Fagerholm; E Ahlqvist; C Forsblom; N Sandholm; A Syreeni; M Parkkonen; A J McKnight; L Tarnow; A P Maxwell; H-H Parving; L Groop; P-H Groop
Journal:  Diabetologia       Date:  2012-05-29       Impact factor: 10.122

2.  A GREM1 gene variant associates with diabetic nephropathy.

Authors:  Amy Jayne McKnight; Christopher C Patterson; Kerry A Pettigrew; David A Savage; Jill Kilner; Madeline Murphy; Denise Sadlier; Alexander P Maxwell
Journal:  J Am Soc Nephrol       Date:  2010-02-11       Impact factor: 10.121

3.  Matrix Metalloproteinase 9 Gene Promoter (rs 3918242) Mutation Reduces the Risk of Diabetic Microvascular Complications.

Authors:  Zhongwen Zhang; Xiaoyun Wu; Tian Cai; Weiyi Gao; Xiaojun Zhou; Junyu Zhao; Jinming Yao; Hongxia Shang; Jianjun Dong; Lin Liao
Journal:  Int J Environ Res Public Health       Date:  2015-07-14       Impact factor: 3.390

4.  Association analysis of dyslipidemia-related genes in diabetic nephropathy.

Authors:  Gareth J McKay; David A Savage; Christopher C Patterson; Gareth Lewis; Amy Jayne McKnight; Alexander P Maxwell
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.